Summary & Overview
CPT 47383: Percutaneous Cryoablation of Liver Tumors
CPT code 47383 represents percutaneous cryosurgical ablation of one or more liver tumors, a minimally invasive technique that freezes tumor tissue to achieve local control. This code is clinically significant as percutaneous tumor ablation is an important alternative or adjunct to surgical resection and thermal ablation methods for selected patients with primary or metastatic liver lesions. Nationally, utilization intersects oncology, interventional radiology, and outpatient procedural care pathways, affecting payer coverage and authorization workflows.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and typical service settings, payer coverage considerations, and common billing modifiers associated with procedural variations. The publication provides benchmarks where available, summaries of relevant policy updates that influence coverage and site-of-service decisions, and practical billing considerations such as documentation elements that support medical necessity for percutaneous cryoablation.
The content is intended for revenue cycle professionals, interventional radiologists, surgical oncologists, and policy analysts seeking a national-level reference for coding and payer interactions related to percutaneous liver cryoablation under CPT code 47383. Data not available in the input will be noted where applicable.
Billing Code Overview
CPT code 47383 describes percutaneous cryosurgical ablation of one or more liver tumors. The procedure uses a freezing technique (cryosurgery) to ablate tumor tissue and is performed through the skin via percutaneous approach.
Service type: Percutaneous tumor ablation (cryosurgery)
Typical site of service: Interventional radiology suite or other percutaneous procedural setting, commonly performed in outpatient procedural units or inpatient interventional suites depending on clinical complexity and patient status.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with a history of colorectal cancer presents with one or more suspicious hepatic lesions on surveillance imaging. Cross-sectional imaging (contrast-enhanced CT or MRI) demonstrates one or two discrete liver metastases amenable to percutaneous ablation. The interventional radiology team schedules a percutaneous cryoablation of the liver tumors performed under conscious sedation or general anesthesia in an outpatient interventional suite or hospital interventional radiology (IR) department.
Pre-procedure workflow includes review of recent imaging and labs (coagulation profile, platelets), informed consent discussing risks (bleeding, infection, adjacent organ injury), and percutaneous planning with ultrasound or CT guidance. During the procedure, the operator inserts cryoprobes through the skin into the target lesions using image guidance, performs controlled freeze–thaw cycles to ablate tumor tissue, monitors iceball formation, and confirms ablation extent. Post-procedure monitoring occurs in recovery for vital signs, pain control, and evaluation for immediate complications prior to discharge with follow-up imaging planned to assess treatment response.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Primary procedure | When this cryoablation is the primary service for the encounter. |